Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca head and neck cancer trials
-
Lynparza Phase III SOLO-2 trial shows significant progression-free survival benefit
-
FDA accepts for review New Drug Application for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalaemia
-
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
-
AstraZeneca enters agreement with Aralez for beta-blocker medicine Toprol-XL in the US
-
AstraZeneca reports top-line results from the Brilinta EUCLID trial in patients with peripheral artery disease
-
MedImmune out-licenses potential medicine for inflammatory diseases to Allergan
-
AstraZeneca presents new data on Faslodex in breast cancer and provides immuno-oncology update at ESMO 2016 congress
-
AstraZeneca provides update on cediranib EU marketing authorisation application
-
Phase III combination trial of Bydureon and Forxiga shows significant benefits in patients with type-2 diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
